Efficacy and safety of transarterial chemoembolization plus lenvatinib combined with PD-1 inhibitors versus transarterial chemoembolization plus lenvatinib for unresectable hepatocellular carcinoma: a meta-analysis

BackgroundLocoregional treatment combined with systemic therapy is expected to play a synergistic anticancer role. We conducted this systemic meta-analysis to examine the efficacy and safety of transarterial chemoembolization (TACE) plus lenvatinib with or without programmed cell death protein-1 (PD...

Повний опис

Бібліографічні деталі

Автори:	Yue Chen, Luyao Jia, Yu Li, Wenhao Cui, Jukun Wang, Chao Zhang, Chunjing Bian, Tao Luo
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Frontiers Media S.A. 2024-08-01
Серія:	Frontiers in Immunology
Предмети:	transarterial chemoembolization lenvatinib programmed cell death protein-1 inhibitors unresectable hepatocellular carcinoma
Онлайн доступ:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1466113/full
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!